Elizaveta Limenis

Biography

Elizaveta Limenis From the Hospital for Sick Children, Division of Rheumatology; Dalla Lana School of Public Health, University of Toronto; Public Health Ontario; Toronto Public Health, Toronto; McMaster University, McMaster Children's Hospital, Hamilton; School of Rural and Northern Health, Laurentian University, Sudbury, Ontario; Dalhousie University, IWK Health Centre, Halifax, Nova Scotia; McGill University, Montreal Children's Hospital, Montreal, Quebec, Canada; University of Bristol, Bristol Royal Hospital for Children, Bristol, UK. Earlier phase of this study supported by Pfizer Inc. through an unrestricted research grant. E. Limenis, BSc, MD, University of Toronto, Hospital for Sick Children; B.M. Feldman, MD, MSc, FRCPC, University of Toronto, Hospital for Sick Children, Dalla Lana School of Public Health; C. Achonu, BSc, MHSc, Public Health Ontario; M. Batthish, MD, MSc, FRCPC, McMaster University, McMaster Children's Hospital; B. Lang, MD, FRCPC, Dalhousie University, IWK Health Centre; M. Mclimont, BSc, MSc, Hospital for Sick Children; S. Ota, BSc, MHSc, Toronto Public Health; A. Ramanan, FRCP, University of Bristol, Bristol Royal Hospital for Children; R. Scuccimarri, MD, FRCPC, McGill University, Montreal Children's Hospital; N.L. Young, BScPT, MSc, PhD, School of Rural and Northern Health, Laurentian University; R. Schneider, MBBCh, FRCPC, University of Toronto, Hospital for Sick Children. Address correspondence to Dr. B.M. Feldman, Division of Rheumatology, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. E-mail: brian.feldman@sickkids.ca. Accepted for publication May 10, 2017. working as a professor in McGill University, Canada. Elizaveta Limenis From the Hospital for Sick Children, Division of Rheumatology; Dalla Lana School of Public Health, University of Toronto; Public Health Ontario; Toronto Public Health, Toronto; McMaster University, McMaster Children's Hospital, Hamilton; School of Rural and Northern Health, Laurentian University, Sudbury, Ontario; Dalhousie University, IWK Health Centre, Halifax, Nova Scotia; McGill University, Montreal Children's Hospital, Montreal, Quebec, Canada; University of Bristol, Bristol Royal Hospital for Children, Bristol, UK. Earlier phase of this study supported by Pfizer Inc. through an unrestricted research grant. E. Limenis, BSc, MD, University of Toronto, Hospital for Sick Children; B.M. Feldman, MD, MSc, FRCPC, University of Toronto, Hospital for Sick Children, Dalla Lana School of Public Health; C. Achonu, BSc, MHSc, Public Health Ontario; M. Batthish, MD, MSc, FRCPC, McMaster University, McMaster Children's Hospital; B. Lang, MD, FRCPC, Dalhousie University, IWK Health Centre; M. Mclimont, BSc, MSc, Hospital for Sick Children; S. Ota, BSc, MHSc, Toronto Public Health; A. Ramanan, FRCP, University of Bristol, Bristol Royal Hospital for Children; R. Scuccimarri, MD, FRCPC, McGill University, Montreal Children's Hospital; N.L. Young, BScPT, MSc, PhD, School of Rural and Northern Health, Laurentian University; R. Schneider, MBBCh, FRCPC, University of Toronto, Hospital for Sick Children. Address correspondence to Dr. B.M. Feldman, Division of Rheumatology, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. E-mail: brian.feldman@sickkids.ca. Accepted for publication May 10, 2017. working as a professor in McGill University, Canada.

Research Interest

Imaging and Interventional Radiology